Chapter 56 Piroplasmosis

  1. Maurer FD: Equine piroplasmosis—another emerging disease. J Am Vet Med Assoc 141:699–702, 1962. PUBMED Abstract
  2. Friedhoff KT, Soule C: An account on equine babesioses. Rev Sci Tech 15:1191–1201, 1996. PUBMED Abstract
  3. de Waal DT: Equine piroplasmosis: a review. Br Vet J 148:6–14, 1992. PUBMED Abstract
  4. Nuttall GH, Sr: Die parasiten der pferdepiroplasmose response der biliary fever. Zentralbl Bakteriol 1:2, 1910.
  5. de Waal DT, van Heerden J: Equine Piroplasmosis. In Coetzer JAW, Tustin RC, editors: Infectious Diseases of Livestock, Cape Town, 2004, Oxford University Press, pp 425–433.
  6. Friedhoff KT, Tenter AM, Muller I: Haemoparasites of equines: impact on international trade of horses. Rev Sci Tech 9:1187–1194, 1990. PUBMED Abstract
  7. Knowles D, Jr: Equine babesiosis (piroplasmosis): a problem in the international movement of horses. Br Vet J 152:123–126, 1996. PUBMED Abstract
  8. Holbrook AA: Biology of equine piroplasmosis. J Am Vet Med Assoc 155:453–454, 1969. PUBMED Abstract
  9. OIE: World Organization of Animal Health. Available at Accessed December 2011.
  10. USDA APHIS: Equine piroplasmosis. Available at Accessed October 2012.
  11. Schein E, Rehbein G, Voigt WP, et al: Babesia equi (Laveran 1901) 1. Development in horses and in lymphocyte culture. Tropenmed Parasitol 32:223–227, 1981. PUBMED Abstract
  12. Mehlhorn H, Schein E: Redescription of Babesia equi Laveran, 1901 as Theileria equi Mehlhorn, Schein 1998. Parasit Res 84:467–475, 1998. PUBMED Abstract
  13. Moltmann UG, Mehlhorn H, Schein E, et al: Fine structure of Babesia equi Laveran, 1901 within lymphocytes and erythrocytes of horses: an in vivo and in vitro study. J Parasitol 69:111–120, 1983. PUBMED Abstract
  14. Brüning A: Equine piroplasmosis an update on diagnosis, treatment and prevention. Br Vet J 152:139–151, 1996. PUBMED Abstract
  15. Allsopp MT, Allsopp BA: Molecular sequence evidence for the reclassification of some Babesia species. Ann N Y Acad Sci 1081:509–517, 2006. PUBMED Abstract
  16. Allsopp MT, Cavalier-Smith T, De Waal DT, et al: Phylogeny and evolution of the piroplasms. Parasit 108(Pt 2):147–152, 1994. PUBMED Abstract
  17. Kappmeyer LS, Thiagarajan M, Herndon DR, et al: Comparative genomic analysis of Theileria equi. BMC Gen 13:603, 2012. PUBMED Abstract
  18. USDA APHIS National Center for Risk Analysis: Equine piroplasmosis domestic pathways assessment 2011: pathways assessment for the spread of the causative agents of equine piroplasmosis from the movement of a horse from a quarantined premises within the contiguous United States. Available at: Accessed October 2012.
  19. Sonenshine DE: Biology of ticks, New York, 1991, Oxford University Press.
  20. Thompson PH: Ticks as vectors of equine piroplasmosis. J Am Vet Med Assoc 155:454–457, 1969. PUBMED Abstract
  21. Ikadai H, Sasaki M, Ishida H, et al: Molecular evidence of Babesia equi transmission in Haemaphysalis longicornis. Am J Trop Med Hyg 76:694–697, 2007. PUBMED Abstract
  22. Scoles GA, Hutcheson HJ, Schlater JL, et al: Equine piroplasmosis associated with Amblyomma cajennense ticks, Texas, USA. Emerg Infect Dis 17:1903–1905, 2011. PUBMED Abstract
  23. De Waal DT: The transovarial transmission of Babesia caballi by Hyalomma truncatum. Onderstepoort J Vet Res 57:99–100, 1990. PUBMED Abstract
  24. Moltmann UG, Mehlhorn H, Schein E, et al: Ultrastructural study on the development of Babesia equi (Coccidia: Piroplasmia) in the salivary glands of its vector ticks. J Protozool 30:218–225, 1983. PUBMED Abstract
  25. Ueti MW, Palmer GH, Scoles GA, et al: Persistently infected horses are reservoirs for intrastadial tick-borne transmission of the apicomplexan parasite Babesia equi. Infect Immun 76:3525–3529, 2008. PUBMED Abstract
  26. Donnellan CM, Marais HJ: Equine Piroplasmosis. In: Mair TS, Hutchinson RE, editors: Infectious Disease of Horses, UK, 2009, EVJ Ltd, pp 333–340.
  27. Short M, Clark C, Harvey J, et al: Review of the equine piroplasmosis outbreak in Florida in 2008. J Am Vet Med Assoc 240:588–595, 2012.
  28. Holbrook AA, Anthony DW, Johnson AJ: Observations on the development of Babesia caballi (Nuttall) in the tropical horse tick Dermacentor nitens Neumann. J Protozool 15:391–396, 1968. PUBMED Abstract
  29. Zapf F, Schein E: The development of Babesia (Theileria) equi (Laveran, 1901) in the gut and the haemolymph of the vector ticks, Hyalomma species. Parasit Res 80:297–302, 1994. PUBMED Abstract
  30. Guimaraes AM, Lima JD, Ribeiro MF, et al: Ultrastructure of sporogony in Babesia equi in salivary glands of adult female Boophilus microplus ticks. Parasit Res 84:69–74, 1998. PUBMED Abstract
  31. Zapf F, Schein E: New findings in the development of Babesia (Theileria) equi (Laveran, 1901) in the salivary glands of the vector ticks, Hyalomma species. Parasit Res 80:543–548, 1994. PUBMED Abstract
  32. Heuchert CM, de Giulli V, Jr, de Athaide DF, et al: Seroepidemiologic studies on Babesia equi and Babesia caballi infections in Brazil. Vet Parasitol 85:1–11, 1999. PUBMED Abstract
  33. Tenter AM, Otte MJ, Gonzalez CA, et al: Prevalence of piroplasmosis in equines in the Colombian province of Cordoba. Trop Anim Health Prod 20:93–98, 1988. PUBMED Abstract
  34. Rhalem A, Sahibi H, Lasri S, et al: Validation of a competitive enzyme-linked immunosorbent assay for diagnosing Babesia equi infections of Moroccan origin and its use in determining the seroprevalence of B. equi in Morocco. J Vet Diagn Invest 13:249–251, 2001. PUBMED Abstract
  35. Barbosa IP, Bose R, Peymann B, et al: Epidemiological aspects of equine babesioses in a herd of horses in Brazil. Vet Parasitol 58:1–8, 1995. PUBMED Abstract
  36. Ikadai H, Nagai A, Xuan X, et al: Seroepidemiologic studies on Babesia caballi and Babesia equi infections in Japan. J Vet Med Sci 64:325–328, 2002. PUBMED Abstract
  37. Boldbaatar D, Xuan X, Battsetseg B, et al: Epidemiological study of equine piroplasmosis in Mongolia. Vet Parasitol 127:29–32, 2005. PUBMED Abstract
  38. Xuan X, Chahan B, Huang X, et al: Diagnosis of equine piroplasmosis in Xinjiang province of China by the enzyme-linked immunosorbent assays using recombinant antigens. Vet Parasitol 108:179–182, 2002. PUBMED Abstract
  39. Xu Y, Zhang S, Huang X, et al: Seroepidemiologic studies on Babesia equi and Babesia caballi infections in horses in Jilin province of China. J Vet Med Sci 65:1015–1017, 2003. PUBMED Abstract
  40. Donnelly J, Joyner LP, Frank C: Quantitative epidemiological studies on the prevalence of babesiosis in horses in Kuwait. Trop Anim Health Prod 12:253–258, 1980. PUBMED Abstract
  41. Basset J, Auger L: Piroplasmose vraie du cheval (P. caballi) dans le sudest. Comp Rend Soc Biol 107:629, 1931.
  42. Viljoen A, Saulez MN, Donnellan CM, et al: After-hours equine emergency admissions at a university referral hospital (1998-2007): causes and interventions. J S Afr Vet Assoc 80:169–173, 2009. PUBMED Abstract
  43. Xuan X, Nagai A, Battsetseg B, et al: Diagnosis of equine piroplasmosis in Brazil by serodiagnostic methods with recombinant antigens. J Vet Med Sci 63:1159–1160, 2001. PUBMED Abstract
  44. Kerber CE, Ferreira F, Pereira MC: Control of equine piroplasmosis in Brazil. Onderstepoort J Vet Res 66:123–127, 1999. PUBMED Abstract
  45. Guimarães AM, Lima JD, Ribeiro MFB: Sporogony and experimental transmission of Babesia equi & Boophilus microplus. Parasit Res 84:323–327, 1998. PUBMED Abstract
  46. Grandi G, Molinari G, Tittarelli M, et al: Prevalence of Theileria equi and Babesia caballi infection in horses from northern Italy. Vector Borne Zoonotic Dis 11:955–956, 2011. PUBMED Abstract
  47. Camacho AT, Guitian FJ, Pallas E, et al: Theileria (Babesia) equi and Babesia caballi infections in horses in Galicia, Spain. Trop Anim Health Prod 37:293–302, 2005. PUBMED Abstract
  48. Sigg L, Gerber V, Gottstein B, et al: Seroprevalence of Babesia caballi and Theileria equi in the Swiss horse population. Parasitol Int 59:313–317, 2010. PUBMED Abstract
  49. Kouam MK, Kantzoura V, Masuoka PM, et al: Genetic diversity of equine piroplasms in Greece with a note on speciation within Theileria genotypes (T. equi and T. equi-like). Infect Genet Evol 10:963–968, 2010. PUBMED Abstract
  50. Criado-Fornelio A, Martinez-Marcos A, Buling-Sarana A, et al: Molecular studies on Babesia, Theileria and Hepatozoon in southern Europe. Part I. Epizootiological aspects. Vet Parasitol 113:189–201, 2003. PUBMED Abstract
  51. Hornok S, Edelhofer R, Foldvari G, et al: Serological evidence for Babesia canis infection of horses and an endemic focus of B. caballi in Hungary. Acta Vet Hung 55:491–500, 2007. PUBMED Abstract
  52. Nikol'skii SN, Baturina FM, Lutsuk SN: [Equine piroplasmosis and nuttaliosis]. Veterinariia 40–41, 1979. PUBMED Abstract
  53. Avarzed A, De Waal DT, Igarashi I, et al: Prevalence of equine piroplasmosis in Central Mongolia. Onderstepoort J Vet Res 64:141–145, 1997. PUBMED Abstract
  54. De Waal DT, Van Heerden J, Van den Berg SS, et al: Isolation of pure Babesia equi and Babesia caballi organisms in splenectomized horses from endemic areas in South Africa. Onderstepoort J Vet Res 55:33–35, 1988. PUBMED Abstract
  55. Zweygarth E, Just MC, De Waal DT: In vitro cultivation of Babesia equi: detection of carrier animals and isolation of parasites. Onderstepoort J Vet Res 64:51–56, 1997. PUBMED Abstract
  56. Littlejohn A, Walker EM: Some aspects of the epidemiology of equine babesiosis. J S Afr Vet Assoc 50:308–310, 1979. PUBMED Abstract
  57. Ellis P: Equine piroplasmosis visits Australia in 2000. Aust Vet J 78:380, 2000.
  58. Martin R: Equine piroplasmosis: the temporary importation of seropositive horses into Australia. Aust Vet J 77:308–309, 1999. PUBMED Abstract
  59. Deleted in proofs.
  60. Bryant JE, Anderson JB, Willers KH: Control of equine piroplasmosis in Florida. J Am Vet Med Assoc 154:1034–1036, 1969. PUBMED Abstract
  61. Ueti MW, Mealey RH, Kappmeyer LS, et al. Re-emergence of the apicomplexan Theileria equi in the United States: elimination of persistent infection and transmission risk. PLoS One 7:e44713, 2012. PUBMED Abstract
  62. Ambawat HK, Malhotra DV, Kumar S, et al: Erythrocyte associated haemato-biochemical changes in Babesia equi infection experimentally produced in donkeys. Vet Parasitol 85:319–324, 1999. PUBMED Abstract
  63. Allen PC, Frerichs WM, Holbrook AA: Experimental acute Babesia caballi infections. II. Response of platelets and fibrinogen. Exp Parasitol 37:373–379, 1975. PUBMED Abstract
  64. Zobba R, Ardu M, Niccolini S, et al: Clinical and laboratory findings in equine piroplasmosis. J Equine Vet Sci 28:301–308, 2008.
  65. Allen PC, Frerichs WM, Holbrook AA: Experimental acute Babesia caballi infections. I. Red blood cell dynamics. Exp Parasitol 37:67–77, 1975. PUBMED Abstract
  66. de Waal DT, van Heerden J, Potgieter FT: An investigation into the clinical pathological changes and serological response in horses experimentally infected with Babesia equi and Babesia caballi. Onderstepoort J Vet Res 54:561–568, 1987. PUBMED Abstract
  67. Allsopp MT, Lewis BD, Penzhorn BL: Molecular evidence for transplacental transmission of Theileria equi from carrier mares to their apparently healthy foals. Vet Parasitol 148:130–136, 2007. PUBMED Abstract
  68. Chhabra S, Ranjan R, Uppal S, et al: Transplacental transmission of Babesia equi (Theileria equi) from carrier mares to foals. J Parasit Dis 1–3, 2011. PUBMED Abstract
  69. Georges KC, Ezeokoli CD, Sparagano O, et al: A case of transplacental transmission of Theileria equi in a foal in Trinidad. Vet Parasitol 175:363–366, 2011. PUBMED Abstract
  70. Phipps LP, Otter A: Transplacental transmission of Theileria equi in two foals born and reared in the United Kingdom. Vet Rec 154:406–408, 2004. PUBMED Abstract
  71. Purchase HS: Piroplasmosis in foal at birth. Vet Rec 59:449, 1947. PUBMED Abstract
  72. Lewis BD, Penzhorn BL, Volkmann DH: Could treatment of pregnant mares prevent abortions due to equine piroplasmosis? J S Afr Vet Assoc 70:90–91, 1999. PUBMED Abstract
  73. Metcalf ES: The role of international transport of equine semen on disease transmission. Anim Reprod Sci 68:229–237, 2001. PUBMED Abstract
  74. Ahmed JS, Glass EJ, Salih DA, et al: Innate immunity to tropical theileriosis. Innate Immun 14:5–12, 2008. PUBMED Abstract
  75. Preston PM, Hall FR, Glass EJ, et al: Innate and adaptive immune responses co-operate to protect cattle against Theileria annulata. Parasitol Today 15:268–274, 1999. PUBMED Abstract
  76. Ahmed JS: The role of cytokines in immunity and immunopathogenesis of pirolasmoses. Parasit Res 88:S48–50, 2002. PUBMED Abstract
  77. Frerichs WM, Johnson AJ, Holbrook AA: Equine piroplasmosis: attempts to infect laboratory animals with Babesia equi. Am J Vet Res 30:1333–1336, 1969. PUBMED Abstract
  78. Kuttler KL, Gipson CA, Goff WL, et al: Experimental Babesia equi infection in mature horses. Am J Vet Res 47:1668–1670, 1986. PUBMED Abstract
  79. Knowles DP, Jr, Kappmeyer LS, Perryman LE: Specific immune responses are required to control parasitemia in Babesia equi infection. Infect Immun 62:1909–1913, 1994. PUBMED Abstract
  80. Guimarães AM, Lima JD, Tafuri WL, et al: Clinical and histopathological aspects of splenectomized foals infected by Babesia equi. J Eq Vet Sci 17:211–216, 1997.
  81. Magnuson NS, Perryman LE, Wyatt CR, et al: Continuous cultivation of equine lymphocytes: evidence for occasional T cell-like maturation events in horses with hereditary severe combined immunodeficiency. J Immunol 133:2518–2524, 1984. PUBMED Abstract
  82. McGuire TC, Banks KL, Poppie MJ: Combined immunodeficiency in horses: characterization of the lymphocyte defect. Clin Immunol Immunopathol 3:555–566, 1975. PUBMED Abstract
  83. Perryman LE, McGuire TC, Crawford TB: Maintenance of foals with combined immunodeficiency: causes and control of secondary infections. Am J Vet Res 39:1043–1047, 1978. PUBMED Abstract
  84. Perryman LE, O'Rourke KI, McGuire TC: Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection. J Virol 62:3073–3076, 1988. PUBMED Abstract
  85. Wiler R, Leber R, Moore BB, et al: Equine severe combined immunodeficiency: a defect in V(D)J recombination and DNA-dependent protein kinase activity. Proc Natl Acad Sci USA 92:11485–11489, 1995. PUBMED Abstract
  86. Hall R, Adamson R, Boulter N: Prime-boost: the way forward for recombinant vaccines against apicomplexan parasites. A Theileria perspective. Parasit Res 88:S45–47, 2002. PUBMED Abstract
  87. Banerjee DP, Singh B, Gautam OP, et al: Cell-mediated immune response in equine babesiosis. Trop Anim Health Prod 9:153–158, 1977. PUBMED Abstract
  88. Zweygarth E, Ahmed JS, Rehbein G, et al: Cell-mediated immune response to Babesia equi-transformed lymphoblastoid cells in vitro. Zentralbl Bakteriol Mikrobiol Hyg A 254:281–289, 1983. PUBMED Abstract
  89. Knowles DP, Jr, Perryman LE, Goff WL, et al: A monoclonal antibody defines a geographically conserved surface protein epitope of Babesia equi merozoites. Infect Immun 59:2412–2417, 1991. PUBMED Abstract
  90. Knowles DP, Jr, Kappmeyer LS, Stiller D, et al: Antibody to a recombinant merozoite protein epitope identifies horses infected with Babesia equi. J Clin Microbiol 30:3122–3126, 1992. PUBMED Abstract
  91. Kumar S, Malhotra DV, Dhar S, et al: Vaccination of donkeys against Babesia equi using killed merozoite immunogen. Vet Parasitol 106:19–33, 2002. PUBMED Abstract
  92. Cunha CW, McGuire TC, Kappmeyer LS, et al: Development of specific immunoglobulin Ga (IgGa) and IgGb antibodies correlates with control of parasitemia in Babesia equi infection. Clin Vaccine Immunol 13:297–300, 2006. PUBMED Abstract
  93. Lewis MJ, Wagner B, Woof JM: The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies. Mol Immunol 45:818–827, 2008. PUBMED Abstract
  94. Tenter AM, Friedhoff KT: Serodiagnosis of experimental and natural Babesia equi and B. caballi infections. Vet Parasitol 20:49–61, 1986. PUBMED Abstract
  95. Donnelly J, Phipps LP, Watkins KL: Evidence of maternal antibodies to Babesia equi and B. caballi in foals of seropositive mares. Equine Vet J 14:126–128, 1982. PUBMED Abstract
  96. Mealey RH, Kappmeyer LS, Ueti MW, et al: Protective effects of passively transferred merozoite-specific antibodies against Theileria equi in horses with severe combined immunodeficiency. Clin Vaccine Immunol, 2011. PUBMED Abstract
  97. Kappmeyer LS, Perryman LE, Hines SA, et al: Detection of equine antibodies to Babesia caballi by recombinant B. caballi rhoptry-associated protein 1 in a competitive-inhibition enzyme-linked immunosorbent assay. J Clin Microbiol 37:2285–2290, 1999. PUBMED Abstract
  98. Brown WC: Molecular approaches to elucidating innate and acquired immune responses to Babesia bovis, a protozoan parasite that causes persistent infection. Vet Parasitol 101:233–248, 2001. PUBMED Abstract
  99. Sippel WL, Cooperrider DE, Gainer JH, et al: Equine piroplasmosis in the United States. J Am Vet Med Assoc. 141:694–698, 1962. PUBMED Abstract
  100. Taylor WM, Bryant JE, Anderson JB, et al: Equine piroplasmosis in the United States—a review. J Am Vet Med Assoc 155:915–919, 1969. PUBMED Abstract
  101. Erbsloh JK: Babesiosis in the newborn foal. J Reprod Fertil Suppl 725–726, 1975. PUBMED Abstract
  102. Oladosu LA: Effects of intravenous corticosteroid on the pathogenicity of Babesia equi infection of donkeys (Equus asinus). Zentralbl Veterinarmed B 35:509–514, 1988. PUBMED Abstract
  103. Oladosu LA, Olufemi BE: Haematology of experimental babesiosis and ehrlichiosis in steroid immunosuppressed horses. Zentralbl Veterinarmed B 39:345–352, 1992. PUBMED Abstract
  104. Hailat NQ, Lafi SQ, al-Darraji AM, et al: Equine babesiosis associated with strenuous exercise: clinical and pathological studies in Jordan. Vet Parasitol 69:1–8, 1997. PUBMED Abstract
  105. Kuttler KL, Goff WL, Gipson CA, et al: Serologic response of Babesia equi-infected horses as measured by complement-fixation and indirect fluorescent antibody tests. Vet Parasitol 26:199–205, 1988. PUBMED Abstract
  106. Rudolph W, Correa J, Zurita L, et al: Equine piroplasmosis: leukocytic response to Babesia equi (Laveran, 1901) infection in Chile. Br Vet J 131:601–609, 1975. PUBMED Abstract
  107. Pitel PH, Pronost S, Scrive T, et al: Molecular detection of Theileria equi and Babesia caballi in the bone marrow of asymptomatic horses. Vet Parasitol 170:182–184, 2010. PUBMED Abstract
  108. Roberts ED, Morehouse LG, Gainer JH, et al: Equine piroplasmosis. J Am Vet Med Assoc 141:1323–1329, 1962. PUBMED Abstract
  109. Mahoney DF, Wright IG, Frerichs WM, et al: The identification of Babesia equi in Australia. Aust Vet J 53:461–464, 1977. PUBMED Abstract
  110. Weiland G: Species-specific serodiagnosis of equine piroplasma infections by means of complement fixation test (CFT), immunofluorescence (IIF), and enzyme-linked immunosorbent assay (ELISA). Vet Parasitol 20:43–48, 1986. PUBMED Abstract
  111. McGuire TC, Van Hoosier GL, Jr, Henson JB: The complement-fixation reaction in equine infectious anemia: demonstration of inhibition by IgG (T). J Immunol 107:1738–1744, 1971. PUBMED Abstract
  112. Cunha CW, Kappmeyer LS, McGuire TC, et al: Conformational dependence and conservation of an immunodominant epitope within the Babesia equi erythrocyte-stage surface protein equi merozoite antigen 1. Clin Diagn Lab Immunol 9:1301–1306, 2002. PUBMED Abstract
  113. Bhoora R, Quan M, Zweygarth E, et al: Sequence heterogeneity in the gene encoding the rhoptry-associated protein-1 (RAP-1) of Babesia caballi isolates from South Africa. Vet Parasitol 169:279–288, 2010. PUBMED Abstract
  114. Bhoora R, Quan M, Matjila PT, et al: Sequence heterogeneity in the equi merozoite antigen gene (ema-1) of Theileria equi and development of an ema-1-specific TaqMan MGB(TM) assay for the detection of T. equi. Vet Parasitol 172:33–45, 2010. PUBMED Abstract
  115. Brüning A, Phipps P, Posnett E, et al: Monoclonal antibodies against Babesia caballi and Babesia equi and their application in serodiagnosis. Vet Parasitol 68:11–26, 1997. PUBMED Abstract
  116. Kumar S, Kumar Y, Malhotra DV, et al: Standardisation and comparison of serial dilution and single dilution enzyme-linked immunosorbent assay (ELISA) using different antigenic preparations of the Babesia (Theileria) equi parasite. Vet Res 34:71–83, 2003. PUBMED Abstract
  117. APHIS: Animal Health Laboratory Information and Services. Available at Accessed October 2012.
  118. Bhoora R, Franssen L, Oosthuizen MC, et al: Sequence heterogeneity in the 18S rRNA gene within Theileria equi and Babesia caballi from horses in South Africa. Vet Parasitol 159:112–120, 2009. PUBMED Abstract
  119. Frerichs WM, Allen PC, Holbrook AA: Equine piroplasmosis (Babesia equi): therapeutic trials of imidocarb dihydrochloride in horses and donkeys. Vet Rec 93:73–75, 1973. PUBMED Abstract
  120. Frerichs WM, Holbrook AA: Treatment of equine piroplasmosis (B. caballi) with imidocarb dipropionate. Vet Rec 95:188–189, 1974. PUBMED Abstract
  121. Kuttler KL, Zaugg JL, Gipson CA: Imidocarb and parvaquone in the treatment of piroplasmosis (Babesia equi) in equids. Am J Vet Res 48:1613–1616, 1987. PUBMED Abstract
  122. Kumar S, Gupta AK, Pal Y, et al: In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys. J Vet Med Sci 65:1171–1177, 2003. PUBMED Abstract
  123. Schwint ON, Ueti MW, Palmer GH, et al: Imidocarb dipropionate clears persistent Babesia caballi infection with elimination of transmission potential. Antimicrob Agents Chemother 53:4327–4332, 2009. PUBMED Abstract
    123a. Grause JF, Ueti MW, Nelson JT, et al: Efficacy of imidocarb dipropionate in eliminating Theileria equi from experimentally infected horses. Vet J, [epub Nov 28 2012]. PUBMED Abstract
  124. Meyer C, Guthrie AJ, Stevens KB: Clinical and clinicopathological changes in 6 healthy ponies following intramuscular administration of multiple doses of imidocarb dipropionate. J S Afr Vet Assoc 76:26–32, 2005. PUBMED Abstract
  125. Adams LG: Clinicopathological aspects of imidocarb dipropionate toxicity in horses. Res Vet Sci 31:54–61, 1981. PUBMED Abstract
  126. Silvey RE: Babesiosis in a foal. Vet Rec 139:428, 1996. PUBMED Abstract
  127. Belloli C, Crescenzo G, Lai O, et al: Pharmacokinetics of imidocarb dipropionate in horses after intramuscular administration. Equine Vet J 34:625–629, 2002. PUBMED Abstract
  128. Rashid H, Chaudhry M, Rashid H, et al: Comparative efficacy of diminazene diaceturate and diminazene aceturate for the treatment of babesiosis in horses. Trop Anim Health Pro 40:463–467, 2008. PUBMED Abstract
  129. Zaugg JL, Lane VM: Evaluations of buparvaquone as a treatment for equine babesiosis (Babesia equi). Am J Vet Res 50:782–785, 1989. PUBMED Abstract
  130. Suarez CE, Noh S: Emerging perspectives in the research of bovine babesiosis and anaplasmosis. Vet Parasitol 180:109–125, 2011. PUBMED Abstract
  131. Thomford JW, Conrad PA, Telford SR, 3rd, et al: Cultivation and phylogenetic characterization of a newly recognized human pathogenic protozoan. J Infect Dis 169:1050–1056, 1994. PUBMED Abstract
  132. Cable RG, Leiby DA: Risk and prevention of transfusion-transmitted babesiosis and other tick-borne diseases. Curr Opin Hematol 10:405–411, 2003. PUBMED Abstract